Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 21

1.
2.

Atomoxetine: a review of its use in attention-deficit hyperactivity disorder in children and adolescents.

Garnock-Jones KP, Keating GM.

Paediatr Drugs. 2009;11(3):203-26. doi: 10.2165/00148581-200911030-00005. Review.

PMID:
19445548
3.

Attention-deficit-hyperactivity disorder: an update.

Dopheide JA, Pliszka SR.

Pharmacotherapy. 2009 Jun;29(6):656-79. doi: 10.1592/phco.29.6.656. Review.

PMID:
19476419
4.

Antidepressants in the treatment of adult attention-deficit hyperactivity disorder: a systematic review.

Verbeeck W, Tuinier S, Bekkering GE.

Adv Ther. 2009 Feb;26(2):170-84. doi: 10.1007/s12325-009-0008-7. Epub 2009 Feb 23. Review.

PMID:
19238340
5.

Varenicline: a first-line treatment option for smoking cessation.

Garrison GD, Dugan SE.

Clin Ther. 2009 Mar;31(3):463-91. doi: 10.1016/j.clinthera.2009.03.021. Review.

PMID:
19393839
6.

Bupropion for adults with attention-deficit hyperactivity disorder: meta-analysis of randomized, placebo-controlled trials.

Maneeton N, Maneeton B, Srisurapanont M, Martin SD.

Psychiatry Clin Neurosci. 2011 Dec;65(7):611-7. doi: 10.1111/j.1440-1819.2011.02264.x. Review.

7.

Evolution of the treatment of attention-deficit/hyperactivity disorder in children: a review.

Findling RL.

Clin Ther. 2008 May;30(5):942-57. doi: 10.1016/j.clinthera.2008.05.006. Review.

PMID:
18555941
8.

A review of the efficacy of smoking-cessation pharmacotherapies in nonwhite populations.

Robles GI, Singh-Franco D, Ghin HL.

Clin Ther. 2008 May;30(5):800-12. doi: 10.1016/j.clinthera.2008.05.010. Review.

PMID:
18555928
9.

ADHD through the life span: the role of bupropion in treatment.

Cantwell DP.

J Clin Psychiatry. 1998;59 Suppl 4:92-4. Review.

10.

Onset of efficacy of long-acting psychostimulants in pediatric attention-deficit/hyperactivity disorder.

Brams M, Mao AR, Doyle RL.

Postgrad Med. 2008 Sep;120(3):69-88. doi: 10.3810/pgm.2008.09.1909. Review.

PMID:
18824827
11.

A qualitative review of issues arising in the use of psycho-stimulant medications in patients with ADHD and co-morbid substance use disorders.

Kollins SH.

Curr Med Res Opin. 2008 May;24(5):1345-57. doi: 10.1185/030079908X280707 . Epub 2008 Apr 1. Review.

PMID:
18384709
12.

Pharmacotherapy of adult attention deficit/hyperactivity disorder: a review.

Wilens TE, Biederman J, Spencer TJ, Prince J.

J Clin Psychopharmacol. 1995 Aug;15(4):270-9. Review.

PMID:
7593710
13.

Nonstimulant therapies for attention-deficit hyperactivity disorder (ADHD) in children and adults.

Waxmonsky JG.

Essent Psychopharmacol. 2005;6(5):262-76. Review.

PMID:
16222911
14.

First-onset tics in patients with attention-deficit-hyperactivity disorder: impact of stimulants.

Roessner V, Robatzek M, Knapp G, Banaschewski T, Rothenberger A.

Dev Med Child Neurol. 2006 Jul;48(7):616-21. Review.

15.

Bupropion overdose in an adolescent.

Ayers S, Tobias JD.

Pediatr Emerg Care. 2001 Apr;17(2):104-6. Review.

PMID:
11334088
16.

[Attention deficit hyperactivity syndrome].

Sell-Salazar F.

Rev Neurol. 2003 Aug 16-31;37(4):353-8. Review. Spanish.

17.

Nonstimulant treatment of adult attention-deficit/hyperactivity disorder.

Spencer T, Biederman J, Wilens T.

Psychiatr Clin North Am. 2004 Jun;27(2):373-83. Review.

PMID:
15064003
18.

Extended-release bupropion: an antidepressant with a broad spectrum of therapeutic activity?

Clayton AH.

Expert Opin Pharmacother. 2007 Mar;8(4):457-66. Review.

PMID:
17309340
19.

The role of dopaminergic agents in improving quality of life in major depressive disorder.

IsHak WW, Davis M, Jeffrey J, Balayan K, Pechnick RN, Bagot K, Rapaport MH.

Curr Psychiatry Rep. 2009 Dec;11(6):503-8. Review.

PMID:
19909674
20.

Advances in alternative pharmacotherapy of ADHD.

Pityaratstian N.

J Med Assoc Thai. 2005 Sep;88 Suppl 4:S357-62. Review.

PMID:
16623055

Supplemental Content

Support Center